BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 12860903)

  • 1. Additive protection of the ischemic heart ex vivo by combined treatment with delta-protein kinase C inhibitor and epsilon-protein kinase C activator.
    Inagaki K; Hahn HS; Dorn GW; Mochly-Rosen D
    Circulation; 2003 Aug; 108(7):869-75. PubMed ID: 12860903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardioprotection by epsilon-protein kinase C activation from ischemia: continuous delivery and antiarrhythmic effect of an epsilon-protein kinase C-activating peptide.
    Inagaki K; Begley R; Ikeno F; Mochly-Rosen D
    Circulation; 2005 Jan; 111(1):44-50. PubMed ID: 15611364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased particulate partitioning of PKC epsilon reverses susceptibility of phospholamban knockout hearts to ischemic injury.
    Gregory KN; Hahn H; Haghighi K; Marreez Y; Odley A; Dorn GW; Kranias EG
    J Mol Cell Cardiol; 2004 Feb; 36(2):313-8. PubMed ID: 14871559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase C isoform-dependent myocardial protection by ischemic preconditioning and potassium cardioplegia.
    Lu K; Otani H; Yamamura T; Nakao Y; Hattori R; Ninomiya H; Osako M; Imamura H
    J Thorac Cardiovasc Surg; 2001 Jan; 121(1):137-48. PubMed ID: 11135170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible involvement of PKC-delta in the abrogated cardioprotective potential of ischemic preconditioning in hyperhomocysteinemic rat hearts.
    Rohilla A; Singh G; Singh M; Bala kumar P
    Biomed Pharmacother; 2010 Mar; 64(3):195-202. PubMed ID: 19914792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase C-epsilon is responsible for the protection of preconditioning in rabbit cardiomyocytes.
    Liu GS; Cohen MV; Mochly-Rosen D; Downey JM
    J Mol Cell Cardiol; 1999 Oct; 31(10):1937-48. PubMed ID: 10525430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of graft coronary artery disease by a brief treatment with a selective epsilonPKC activator and a deltaPKC inhibitor in murine cardiac allografts.
    Tanaka M; Terry RD; Mokhtari GK; Inagaki K; Koyanagi T; Kofidis T; Mochly-Rosen D; Robbins RC
    Circulation; 2004 Sep; 110(11 Suppl 1):II194-9. PubMed ID: 15364862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein kinase C-epsilon is a trigger of delayed cardioprotection against myocardial ischemia of kappa-opioid receptor stimulation in rat ventricular myocytes.
    Wang GY; Zhou JJ; Shan J; Wong TM
    J Pharmacol Exp Ther; 2001 Nov; 299(2):603-10. PubMed ID: 11602672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioprotection via activation of protein kinase C-delta depends on modulation of the reverse mode of the Na+/Ca2+ exchanger.
    Bouwman RA; Salic K; Padding FG; Eringa EC; van Beek-Harmsen BJ; Matsuda T; Baba A; Musters RJ; Paulus WJ; de Lange JJ; Boer C
    Circulation; 2006 Jul; 114(1 Suppl):I226-32. PubMed ID: 16820577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The infarct size-limiting effect of ischemic postconditioning (IPOC) is suppressed in isolated hyperhomocysteinemic (Hhcy) rat hearts: the reasonable role of PKC-delta.
    Rohilla A; Balakumar P
    Biomed Pharmacother; 2009 Dec; 63(10):787-91. PubMed ID: 19914793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of heart transplant injury and graft coronary artery disease after prolonged organ ischemia by selective protein kinase C regulators.
    Tanaka M; Gunawan F; Terry RD; Inagaki K; Caffarelli AD; Hoyt G; Tsao PS; Mochly-Rosen D; Robbins RC
    J Thorac Cardiovasc Surg; 2005 May; 129(5):1160-7. PubMed ID: 15867794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Landiolol has cardioprotective effects against reperfusion injury in the rat heart via the PKCepsilon signaling pathway.
    Takahashi Y; Takemura S; Minamiyama Y; Shibata T; Hirai H; Sasaki Y; Sakaguchi M; Suehiro S
    Free Radic Res; 2007 Jul; 41(7):757-69. PubMed ID: 17577736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of delta-protein kinase C protects against reperfusion injury of the ischemic heart in vivo.
    Inagaki K; Chen L; Ikeno F; Lee FH; Imahashi K; Bouley DM; Rezaee M; Yock PG; Murphy E; Mochly-Rosen D
    Circulation; 2003 Nov; 108(19):2304-7. PubMed ID: 14597593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FGF-2-induced negative inotropism and cardioprotection are inhibited by chelerythrine: involvement of sarcolemmal calcium-independent protein kinase C.
    Padua RR; Merle PL; Doble BW; Yu CH; Zahradka P; Pierce GN; Panagia V; Kardami E
    J Mol Cell Cardiol; 1998 Dec; 30(12):2695-709. PubMed ID: 9990540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel cardioprotective role of a small heat-shock protein, Hsp20, against ischemia/reperfusion injury.
    Fan GC; Ren X; Qian J; Yuan Q; Nicolaou P; Wang Y; Jones WK; Chu G; Kranias EG
    Circulation; 2005 Apr; 111(14):1792-9. PubMed ID: 15809372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-specific role for epsilon- and betaI-protein kinase C isozymes in protecting cortical neurons and astrocytes from ischemia-like injury.
    Wang J; Bright R; Mochly-Rosen D; Giffard RG
    Neuropharmacology; 2004 Jul; 47(1):136-45. PubMed ID: 15165841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC.
    Chen L; Hahn H; Wu G; Chen CH; Liron T; Schechtman D; Cavallaro G; Banci L; Guo Y; Bolli R; Dorn GW; Mochly-Rosen D
    Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11114-9. PubMed ID: 11553773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase C betaII peptide inhibitor exerts cardioprotective effects in rat cardiac ischemia/reperfusion injury.
    Omiyi D; Brue RJ; Taormina P; Harvey M; Atkinson N; Young LH
    J Pharmacol Exp Ther; 2005 Aug; 314(2):542-51. PubMed ID: 15878997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioprotective properties of humoral factors released from rat hearts subject to ischemic preconditioning.
    Serejo FC; Rodrigues LF; da Silva Tavares KC; de Carvalho AC; Nascimento JH
    J Cardiovasc Pharmacol; 2007 Apr; 49(4):214-20. PubMed ID: 17438406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenylephrine induces early and late cardioprotection through mitochondrial permeability transition pore in the isolated rat heart.
    Naderi R; Imani A; Faghihi M; Moghimian M
    J Surg Res; 2010 Nov; 164(1):e37-42. PubMed ID: 20850771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.